Targeting tough bacteria: Durham biotech startup advances synthetic antibiotic technology
Editor’s note: Deep Dive – a feature looking in depth at timely issues from tech to jobs – is a regular feature on Wednesdays in TechWire. +++ RESEARCH TRIANGLE PARK - It’s often said that success doesn’t happen overnight. Consider Durham-based anti-infectives startup ValanBio Therapeutics. The journey that led to the development of its new synthetic antibiotic
Source: wraltechwire.com